Matches in SemOpenAlex for { <https://semopenalex.org/work/W90840010> ?p ?o ?g. }
- W90840010 endingPage "229" @default.
- W90840010 startingPage "225" @default.
- W90840010 abstract "Adenovirus infections are a frequent and serious complication following allogeneic haematopoietic stem cell transplantation (HSCT). The antiviral drugs cidofovir and ribavirin have been used as first-line therapy for disseminated infections with variable results. In the present study, in vitro susceptibility to these two drugs was evaluated on HEp-2 cells in adenovirus reference strains representing serotypes of each of the six species and in clinical isolates. Susceptibility to cidofovir was comparable between species with inhibition of replication of all tested serotypes in a narrow dose range (IC50=17-81 microM). However, susceptibility to ribavirin was highly dependent on the species. Serotypes from species A, B, D, E and F were all resistant to ribavirin (IC50=396 to >500 microM). Only replication of serotypes from species C was inhibited by ribavirin (IC50=48-108 microM). This species-dependent susceptibility of adenovirus to ribavirin was confirmed in clinical isolates. When tested on other cell lines (PLC, A549 and 293), all species were revealed to be resistant to ribavirin. If our in vitro findings are predictive of virological responses in vivo, these results suggest that ribavirin would not be effective for management of non-C species adenovirus infections after HSCT." @default.
- W90840010 created "2016-06-24" @default.
- W90840010 creator A5000221571 @default.
- W90840010 creator A5009255625 @default.
- W90840010 creator A5011721730 @default.
- W90840010 creator A5035776513 @default.
- W90840010 creator A5036991991 @default.
- W90840010 creator A5036993173 @default.
- W90840010 creator A5041349895 @default.
- W90840010 creator A5054904756 @default.
- W90840010 creator A5059665410 @default.
- W90840010 creator A5072883938 @default.
- W90840010 creator A5082616655 @default.
- W90840010 date "2005-02-01" @default.
- W90840010 modified "2023-10-11" @default.
- W90840010 title "<i>In Vitro</i> Susceptibility of Adenovirus to Antiviral Drugs is Species-Dependent" @default.
- W90840010 cites W1969283143 @default.
- W90840010 cites W1969788551 @default.
- W90840010 cites W1970353805 @default.
- W90840010 cites W1979440293 @default.
- W90840010 cites W1991302960 @default.
- W90840010 cites W2004756190 @default.
- W90840010 cites W2009035737 @default.
- W90840010 cites W2009665450 @default.
- W90840010 cites W2010758405 @default.
- W90840010 cites W2015663340 @default.
- W90840010 cites W2021686939 @default.
- W90840010 cites W2030143359 @default.
- W90840010 cites W2035789688 @default.
- W90840010 cites W2048726074 @default.
- W90840010 cites W2065258466 @default.
- W90840010 cites W2066019177 @default.
- W90840010 cites W2072141379 @default.
- W90840010 cites W2097640437 @default.
- W90840010 cites W2127243297 @default.
- W90840010 cites W2128840444 @default.
- W90840010 cites W2137748387 @default.
- W90840010 cites W2153666482 @default.
- W90840010 doi "https://doi.org/10.1177/135965350501000204" @default.
- W90840010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15865216" @default.
- W90840010 hasPublicationYear "2005" @default.
- W90840010 type Work @default.
- W90840010 sameAs 90840010 @default.
- W90840010 citedByCount "127" @default.
- W90840010 countsByYear W908400102012 @default.
- W90840010 countsByYear W908400102013 @default.
- W90840010 countsByYear W908400102014 @default.
- W90840010 countsByYear W908400102015 @default.
- W90840010 countsByYear W908400102016 @default.
- W90840010 countsByYear W908400102017 @default.
- W90840010 countsByYear W908400102018 @default.
- W90840010 countsByYear W908400102019 @default.
- W90840010 countsByYear W908400102020 @default.
- W90840010 countsByYear W908400102021 @default.
- W90840010 countsByYear W908400102022 @default.
- W90840010 countsByYear W908400102023 @default.
- W90840010 crossrefType "journal-article" @default.
- W90840010 hasAuthorship W90840010A5000221571 @default.
- W90840010 hasAuthorship W90840010A5009255625 @default.
- W90840010 hasAuthorship W90840010A5011721730 @default.
- W90840010 hasAuthorship W90840010A5035776513 @default.
- W90840010 hasAuthorship W90840010A5036991991 @default.
- W90840010 hasAuthorship W90840010A5036993173 @default.
- W90840010 hasAuthorship W90840010A5041349895 @default.
- W90840010 hasAuthorship W90840010A5054904756 @default.
- W90840010 hasAuthorship W90840010A5059665410 @default.
- W90840010 hasAuthorship W90840010A5072883938 @default.
- W90840010 hasAuthorship W90840010A5082616655 @default.
- W90840010 hasBestOaLocation W908400101 @default.
- W90840010 hasConcept C10389963 @default.
- W90840010 hasConcept C159047783 @default.
- W90840010 hasConcept C202751555 @default.
- W90840010 hasConcept C2522874641 @default.
- W90840010 hasConcept C2776408679 @default.
- W90840010 hasConcept C2776824251 @default.
- W90840010 hasConcept C2780040827 @default.
- W90840010 hasConcept C54355233 @default.
- W90840010 hasConcept C86803240 @default.
- W90840010 hasConceptScore W90840010C10389963 @default.
- W90840010 hasConceptScore W90840010C159047783 @default.
- W90840010 hasConceptScore W90840010C202751555 @default.
- W90840010 hasConceptScore W90840010C2522874641 @default.
- W90840010 hasConceptScore W90840010C2776408679 @default.
- W90840010 hasConceptScore W90840010C2776824251 @default.
- W90840010 hasConceptScore W90840010C2780040827 @default.
- W90840010 hasConceptScore W90840010C54355233 @default.
- W90840010 hasConceptScore W90840010C86803240 @default.
- W90840010 hasIssue "2" @default.
- W90840010 hasLocation W908400101 @default.
- W90840010 hasLocation W908400102 @default.
- W90840010 hasOpenAccess W90840010 @default.
- W90840010 hasPrimaryLocation W908400101 @default.
- W90840010 hasRelatedWork W1487857142 @default.
- W90840010 hasRelatedWork W1985234536 @default.
- W90840010 hasRelatedWork W2080201031 @default.
- W90840010 hasRelatedWork W2084311868 @default.
- W90840010 hasRelatedWork W2099413611 @default.
- W90840010 hasRelatedWork W2103920410 @default.